NR1H4 and metabolic syndrome: Furthermore, FXR activation on rat aortic smooth muscle cells also leads to the increased expression of the angiotensin II type 2 receptor, with its vasodilatory function [95], with the possible beneficial effect of FXR agonists on atherosclerosis [96], diabetes, and metabolic syndrome [97], even if literature on this topic is still poor.